IPCA Laboratories
Soumya Ranjan Mishra is an experienced professional in the pharmaceutical sector, currently serving as a Senior Research Associate-PDR at Ipca Laboratories Limited since October 2024, focusing on the development of generic drugs for diverse international markets. Prior to this role, Soumya Ranjan Mishra worked at Medley Pharmaceuticals Ltd as a Research Associate, engaging in new product development and optimization projects from September 2022 to October 2024. Experience includes a position at Corona Remedies Pvt Ltd as a Research Associate for formulation and development and serving as an Executive-F&D at Stanford Laboratories Pvt. Ltd., where responsibilities included product development and technology transfer. Soumya Ranjan Mishra's early career involved serving as a Research and Development Executive at Medopharm, executing various studies and regulatory documentation. Educational qualifications include a Bachelor of Pharmacy from Indira Gandhi Institute of Pharmaceutical Sciences and a Master's degree in Pharmaceutics and Drug Design from Biju Patnaik University of Technology, Odisha.
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.